中国肺癌杂志2017，Vol.20Issue(9)：641-644,4.DOI:10.3779/j.issn.1009-3419.2017.09.09
肺原位腺癌的诊断与治疗进展
Advance in Diagnose and Treatment Strategies of Adenocarcinoma in Situ
裘杨波1
作者信息
- 1. 200039上海,上海交通大学附属胸科医院/上海市肺部肿瘤临床医学中心
- 折叠
摘要
Abstract
Adenocarcinoma in situ (AIS) is a new concept which was introduced to the 2011 The International Association for the Study of Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) International Multidisciplinary Classification of Lung Adenocarcinoma firstly and an important supplement ofThe 2015 World Health Organization Classification of Lung Tumors.Because AIS is at an early stage of development of lung adenocarcinoma,the deepening understanding of its pathology,differential diagnosis,treatment strategies,has an important significance for the improvement of the prognosis of lung adenocarcinoma.This review will provide a systematic review of the main progress of occurrence and development,pathological characteristics,differential diagnosis and treatment strategy of AIS,in order to provide theoretical basis for the further research of AIS.关键词
肺原位腺癌/病理特征/诊断/治疗Key words
Adenocarcinoma in situ/Pathological characteristics/Diagnosis/Treatment引用本文复制引用
裘杨波..肺原位腺癌的诊断与治疗进展[J].中国肺癌杂志,2017,20(9):641-644,4.
